Olaris, Inc.
PrivateLast Round
Series B
Extension
Apr 8, 2025
Total Funding Raised
$62,500
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Olaris, Inc. is a biotechnology company that develops precision diagnostics by integrating metabolomics and machine learning to identify metabolite signatures for clinical decision-making.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Healthcare Analytics, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Olaris, Inc. Comparables
Compare Olaris, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Verici Dx plc | 77% | |
| Eurofins Scientific SE | 74% | |
| CareDx | 73% |
Olaris, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Apr 8, 2025 | ||||
| Grant | Feb 11, 2020 | ||||
| Series A | Jun 20, 2019 | ||||
| Grant | Jun 20, 2018 |
Key People
Founding team and executive leadership
Olaris, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pear Tree Partners | Series B Extension |
| Massachusetts Life Sciences Center | Grant |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| InnoSpark Ventures | Series B Extension, Series A |
| Alumni Ventures | Series B Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 25, 2026
Grew 19% QoQ, from 16 to 19 employees.
- Apr 29, 2026
Grew 20% QoQ, from 15 to 18 employees.
Olaris, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Olaris, Inc.'s valuation, stock price, and market status.
Is Olaris, Inc. a public or private company?
Olaris, Inc. is a private company.
What is the current stock price of Olaris, Inc.?
Olaris, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Olaris, Inc. worth (valuation)?
Valuation information for Olaris, Inc. is not publicly available.
Can I buy Olaris, Inc. stock?
Olaris, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Olaris, Inc.'s last funding round?
Olaris, Inc.'s most recent funding round was Series B Extension on April 8, 2025.
Who are the main investors in Olaris, Inc.?
Key investors in Olaris, Inc. include Pear Tree Partners, Massachusetts Life Sciences Center, The Michael J. Fox Foundation for Parkinson's Research, InnoSpark Ventures, Alumni Ventures.
Will Olaris, Inc. IPO soon?
No public IPO plans have been announced for Olaris, Inc..
How can I track Olaris, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Olaris, Inc.'s secondary market activity and sign up for updates.